Krystal Biotech EPS Basic from Accounting Change (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

253.68 +1.51 (+0.60%) USD | NASDAQ | Dec 29, 16:00

253.67 -0.01 (-0.00%) After-Hours: 20:00

View EPS Basic from Accounting Change (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

DexCom, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Vanda Pharmaceuticals, Inc.	--
ADMA Biologics, Inc.	--
Aldeyra Therapeutics, Inc.	--